Research Topics
Species | S GardinerSummaryCountry: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Fifteen years of drug information in Christchurch HospitalS Gardiner
Department of Clinical Pharmacology, Christchurch School of Medicine
N Z Med J 114:393-5. 2001..To determine changes in numbers, demography and type of questions posed to the drug information service (DIS) at Christchurch Hospital over the last fifteen years...
Breastfeeding during tacrolimus therapySharon J Gardiner
Department of Medicine, Christchurch School of Medicine and Christchurch Hospital, Christchurch, New Zealand
Obstet Gynecol 107:453-5. 2006..Limited data suggest that infant exposure to tacrolimus via milk is low. This report characterizes the milk-to-blood ratio for tacrolimus using area under the concentration-time curve analysis in a renal transplant patient...
Transfer of rofecoxib into human milkSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand
Eur J Clin Pharmacol 61:405-8. 2005..To determine the milk-to-plasma (M/P) concentration ratio of rofecoxib in lactating mothers and estimate likely infant exposure...
Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?Sharon J Gardiner
Department of Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
Pharmacogenet Genomics 15:365-9. 2005..The low clinical utilization reflects a poor evidence base, unestablished clinical relevance and, in the few cases with the strongest rationale, a slow translation to the clinical setting...
Genotyping for drug-metabolizing enzymes--does the promise meet the reality?Sharon J Gardiner
Department of Medicine, Christchurch School of Medicine, Private Bag 4345, Christchurch, New Zealand
Pharmacogenomics 5:1033-6. 2004
Pharmacogenetics, drug-metabolizing enzymes, and clinical practiceSharon J Gardiner
Department of Medicine, Christchurch School of Medicine, Private Bag 4345, Christchurch, New Zealand
Pharmacol Rev 58:521-90. 2006..In this review we summarize the current evidence base for pharmacogenetics in relation to drug-metabolizing enzymes...
Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairsSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand
Br J Clin Pharmacol 62:453-6. 2006..To determine infant exposure to 6-thioguanine and 6-methylmercaptopurine nucleotides (6-TGN and 6-MMPN, respectively) during maternal use of azathioprine in breastfeeding...
Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprineSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Private Bag, Christchurch, New Zealand
Br J Clin Pharmacol 62:473-6. 2006..CONCLUSIONS: Testing for TPMT ideally should be performed in every patient commencing a thiopurine drug...
Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infantsSharon J Gardiner
Department of Clinical Pharmacology, Christchurh Hospital, New Zealand
Am J Psychiatry 160:1428-31. 2003..This study characterized infant drug doses and breast-milk-to-plasma area-under-the-curve ratios for olanzapine and determined plasma concentrations and effects of this drug on breast-feeding infants...
Transfer of metformin into human milkSharon J Gardiner
Department of Clinical Pharmacology and Diabetes Centre, Christchurch Hospital, Christchurch, New Zealand
Clin Pharmacol Ther 73:71-7. 2003..Our objectives were to determine the milk-to-plasma ratio of metformin in lactating mothers and to estimate infant exposure...
Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-foldSharon J Gardiner
Department of Medicine, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand
Clin Gastroenterol Hepatol 6:654-60; quiz 604. 2008..The purpose of this study was to determine thiopurine dose requirements in intermediate versus normal TPMT metabolism status...
Quantification of infant exposure to celecoxib through breast milkSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand
Br J Clin Pharmacol 61:101-4. 2006..To determine the milk-to-plasma (M/P) concentration ratio of celecoxib, and estimate likely infant exposure...
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel diseaseVirginia L Priest
Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand
Pharmacoeconomics 24:767-81. 2006..Prospective testing for poor metabolisers of AZA may also be cost effective, with phenotype testing likely to be more cost effective than genotype testing...
Development and validation of a stereoselective liquid chromatography-tandem mass spectrometry assay for quantification of S- and R-metoprolol in human plasmaBerit P Jensen
Clinical Pharmacology, Department of Medicine, University of Otago, Christchurch, New Zealand
J Chromatogr B Analyt Technol Biomed Life Sci 865:48-54. 2008..5 microg/L representing the limit of quantification. In this range, relative standard deviations were <6% for intra-day precision and <10% for inter-day precision. The accuracy was within the range of 92-105%...
Determination of celecoxib in human plasma and breast milk by high-performance liquid chromatographic assayMei Zhang
Clinical Pharmacology, Department of Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand
J Chromatogr B Analyt Technol Biomed Life Sci 830:245-8. 2006..99). Bias was </=+/-15% from 20 to 2000 microg/L in both matrices, intra- and inter-day coefficients of variation (imprecision) were <10%, and the limit of quantification was 10 microg/L...
Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milkMei Zhang
Department of Clinical Pharmacology, Christchurch Hospital, New Zealand
J Chromatogr B Analyt Technol Biomed Life Sci 766:175-9. 2002..Standard curves were linear over the concentration range 20.0-4000 microg/l. Intra- and inter-day coefficients of variation were <9.0% and the limit of quantification was around 20 microg/l...
Determination of rofecoxib in human plasma and breast milk by high-performance liquid chromatographic assayMei Zhang
Department of Clinical Pharmacology, Christchurch School of Medicine and Health Sciences, University of Otago, P O Box 4345, Christchurch, New Zealand
J Chromatogr B Analyt Technol Biomed Life Sci 807:217-21. 2004..Standard curves were linear over the concentration range 10-2000 microg/L (r2 >0.99). Intra- and inter-day coefficients of variation for both matrices were <10% and the limit of quantification was around 10 microg/L...
Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotidesSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital, University of Otago, Christchurch, New Zealand
Eur J Gastroenterol Hepatol 20:1238-42. 2008..These cases illustrate a risk with thiopurine dose adjustment based on monitoring of 6-TGN metabolites without also monitoring 6-MMPN...
The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracilSharon J Gardiner
Department of Clinical Pharmacology, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand
Adverse Drug React Toxicol Rev 21:1-16. 2002..Despite the considerable inroads that have been made, further study is needed before the best means of optimising fluorouracil treatment is determined...
Transfer of risperidone and 9-hydroxyrisperidone into human milkKenneth F Ilett
Pharmacology Unit, School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia
Ann Pharmacother 38:273-6. 2004..3%, 2.8%, and 4.7% (as risperidone equivalents) of the maternal weight-adjusted doses. Risperidone and 9-hydroxyrisperidone were not detected in the plasma of the 2 breast-fed infants studied, and no adverse effects were noted...
Thiopurine treatment in inflammatory bowel diseaseSharon J Gardiner
Clin Pharmacokinet 46:803-4; author reply 805. 2007
Metformin therapy and diabetes in pregnancySharon J Gardiner
Med J Aust 181:174-5; author reply 175. 2004
Comment: Breast-feeding during maternal use of azathioprineSharon J Gardiner
Ann Pharmacother 41:719-20; author reply 720. 2007
Prediction of milk/plasma concentration ratio of drugsMatthew P Doogue
Ann Pharmacother 38:174-6; author's reply 176. 2004
